These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8177462)

  • 1. [Adenocarcinoma of the endocervix. Clinical cases].
    Zarcone R; Tartaglia E; Cardone G; Voto RI
    Minerva Ginecol; 1994; 46(1-2):45-8. PubMed ID: 8177462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
    Schild R; Kutta T
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):467-70. PubMed ID: 1397942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histological significance of atypical glandular cell on Pap smear.
    Behtash N; Nazari Z; Fakhrejahani F; Khafaf A; Azar EG
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):46-9. PubMed ID: 17261100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ThinPrep Pap test of endocervical adenocarcinoma with lymph node metastasis: report of a case in a 17-year-old woman.
    Wagner DG; Weisensel J; Mentrikoski MJ; Leo SD; Bonfiglio TA; Hoda RS
    Diagn Cytopathol; 2010 Sep; 38(9):633-8. PubMed ID: 19941367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
    Pretorius R; Binstock M; Sadeghi M; Hodges W
    J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of Pap smear cytology in the Western region of Saudi Arabia.
    Jamal A; Al-Maghrabi JA
    Saudi Med J; 2003 Nov; 24(11):1225-9. PubMed ID: 14647558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
    Bai H; Sung CJ; Steinhoff MM
    Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adenocarcinoma of the endocervix in material submitted to a central cytodiagnostic laboratory].
    Munck C
    Zentralbl Gynakol; 1984; 106(7):456-62. PubMed ID: 6730767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subdividing atypical glandular cells of undetermined significance according to the Australian modified Bethesda, system: analysis of outcomes.
    Roberts JM; Thurloe JK; Bowditch RC; Laverty CR
    Cancer; 2000 Apr; 90(2):87-95. PubMed ID: 10794157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimal deviation endocervical adenocarcinoma--clinical, histologic and immunohistochemical study].
    Zhang JM
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):275-7. PubMed ID: 2625109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glandular cells in a cervical smear.
    Juric D; Ovanin-Rakić A; Audy-Jurković S; Kani D; Ilić-Forko J; Buković D
    Cytopathology; 2006 Oct; 17(5):299-300. PubMed ID: 16961660
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology.
    Zweizig S; Noller K; Reale F; Collis S; Resseguie L
    Gynecol Oncol; 1997 May; 65(2):314-8. PubMed ID: 9159344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.